Patient Registry Software Market

Market Overview The Global Patient Registry Software Market is projected to expand significantly, rising from USD 2.68 Billion in 2025 to USD 4.71 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 9.85%. This specialized digital solution is designed to meticulously collect, store, and analyze standardized data on individuals with specific diseases or conditions. Such systems are crucial for evaluating clinical outcomes, supporting post-market surveillance, and advancing the development of orphan drugs. Key drivers for this market include the escalating demand from regulatory bodies for Real-World Evidence (RWE) to validate clinical trials and expedite drug approvals, the increasing global prevalence of chronic and rare diseases requiring robust longitudinal tracking, and the healthcare industry's shift towards value-based care, which promotes these platforms for enhanced population health management. Data interoperability and the absence of uniform standards across disparate healthcare systems present a significant challenge for the market, hindering seamless data integration. This fragmentation often creates isolated information silos, impeding the comprehensive analysis vital for multi-site clinical studies. Despite these challenges, there is notable adoption in niche sectors; for instance, in 2025, the IAMRARE registry platform, as reported by the National Organization for Rare Disorders, facilitated over 70 patient-powered natural history studies, encompassing more than 20,000 participants across 165 distinct rare diseases. Market Driver The increasing requirement for Real-World Evidence (RWE) in drug development serves as the primary impetus for the patient registry software market's growth. As regulatory bodies and pharmaceutical companies increasingly seek to corroborate clinical trial findings with extensive longitudinal data from diverse patient populations, the need for platforms capable of aggregating and analyzing vast datasets has soared. This evolution is transforming registries from mere data repositories into dynamic tools crucial for post-marketing surveillance and the creation of synthetic control arms, thus necessitating advanced software infrastructure. To illustrate the magnitude of data now being utilized, Verana Health announced in March 2025 an enhancement to its research capabilities by integrating a real-world database containing de-identified records from up to 80 million patients, aimed at supporting more inclusive clinical studies. Access to such extensive data empowers stakeholders to generate high-quality evidence, thereby accelerating the approval of new therapies while simultaneously reducing the costs and complexities typically associated with traditional trials. Concurrently, the rising incidence of chronic and rare diseases is fueling the broad adoption of registry solutions, essential for effective population health management and the delivery of value-based care. Healthcare systems are increasingly relying on these digital platforms to monitor disease progression, track long-term patient outcomes, and identify suitable participants for specialized research initiatives. This trend is underscored by significant national programs; in February 2025, the National Institutes of Health's All of Us Research Program expanded its dataset to include information from over 633,000 participants, representing a 50% increase in the volume of data available for studying complex health conditions. Furthermore, sustained public sector commitment to these systems is evident through new funding allocations, such as the €8.7 million investment announced by the Andalucía Government in January 2026 for a new care plan that includes the deployment of a specialized registry system to enhance knowledge and services for rare diseases. Market Challenge Data interoperability and the absence of standardized formats across fragmented healthcare systems pose a significant impediment to the growth of the Global Patient Registry Software Market. Patient registries fundamentally depend on the seamless aggregation of longitudinal health data from diverse sources, including various electronic health records, laboratory information systems, and pharmacy databases. When these systems operate in isolation due to incompatible technical standards, the fluid exchange of information becomes obstructed. This fragmentation forces organizations to resort to labor-intensive manual data entry or develop complex custom interfaces, which substantially inflates the operational costs and extends the implementation timeline for registry solutions. Consequently, this discourages potential adopters who require efficient, automated data capture mechanisms. This technical friction directly hinders market expansion by restricting the scalability and immediate practical utility of registry initiatives for both research and value-based care. Healthcare providers are often reluctant to invest in platforms that cannot effectively communicate with their existing infrastructure. According to the Healthcare Information and Management Systems Society, in 2024, 42% of healthcare organizations identified integrating data from multiple electronic health record systems as their most formidable obstacle to improving interoperability. This high degree of difficulty in harmonizing disparate data sources reduces the return on investment for registry buyers, thereby decelerating the broader adoption of these critical software platforms across the entire healthcare ecosystem. Market Trends The integration of Artificial Intelligence (AI) for predictive analytics is profoundly transforming patient registry software by enabling the automated extraction of valuable insights from previously unstructured data sources. While registries traditionally relied on structured fields, advanced machine learning algorithms can now process clinical notes, medical imaging, and pathology reports to more precisely identify eligible trial participants and forecast disease progression. This capability effectively converts dormant text into actionable datasets for complex research, pushing platforms beyond simple data storage. For example, in February 2025, Verana Health, in a corporate press release concerning a new strategic partnership, highlighted its deployment of AI tools to analyze unstructured clinical notes, successfully identifying patients with Retinitis Pigmentosa for gene therapy development who would have been overlooked by standard coding queries. Simultaneously, the increasing use of wearable devices for real-time data capture is expanding the scope of registries, moving beyond episodic clinical visits to continuous physiological monitoring. By ingesting high-frequency patient-generated health data, such as heart rate variability and activity levels, modern platforms can construct a more holistic view of patient health and treatment efficacy in real-world environments. This trend is rapidly increasing both the volume and granularity of longitudinal data available for post-marketing surveillance and chronic disease management. Illustrating this growth, Validic stated in October 2025, during its ecosystem expansion announcement at the HLTH conference, that its wearable data integration platform now supports over 600 connected devices, a capability that allowed a single national provider to enroll more than 500,000 patients into continuous remote monitoring programs. Key Market Players * IBM Corporation * IQVIA Holdings, Inc. * Optum, Inc. * Oracle Corporation * McKesson Corporation * ImageTrend, Inc. * Dacima Software Inc. * Syneos Health Inc. * Global Vision Technologies, Inc. * Evado eClinical Solutions Report Scope In this report, the Global Patient Registry Software Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: # Patient Registry Software Market, By Type of Registry * Disease Registries * Health Service Registries * Product Registries # Patient Registry Software Market, By Type of Software * Stand-alone Software * Integrated Software # Patient Registry Software Market, By End User * Hospitals * Government Organizations and Third-Party Administrators (TPAs) * Pharmaceutical * Biotechnology * Medical Device Companies * Other # Patient Registry Software Market, By Region * North America United States Canada Mexico * Europe France United Kingdom Italy Germany Spain * Asia Pacific China India Japan Australia South Korea * South America Brazil Argentina Colombia * Middle East & Africa South Africa Saudi Arabia UAE Competitive Landscape Company Profiles: Detailed analysis of the major companies present in the Global Patient Registry Software Market. Available Customizations: Global Patient Registry Software Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: Company Information * Detailed analysis and profiling of additional market players (up to five).